Old Web
English
Sign In
Acemap
>
Paper
>
Aducanumab for Alzheimer disease: the amyloid hypothesis moves from bench to bedside.
Aducanumab for Alzheimer disease: the amyloid hypothesis moves from bench to bedside.
2021
Erik S. Musiek
Teresa Gomez-Isla
David M. Holtzman
Keywords:
Neuroscience
Biochemistry of Alzheimer's disease
Alzheimer's disease
bench to bedside
Medicine
Aducanumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
12
References
0
Citations
NaN
KQI
[]